Debbie Schultz actually said...

"It is unacceptable."

"This program is supposed to be used to protect patient safety."

"As a breast cancer survivor, the high cost of cancer treatment is very personal to me."

"Encouraging generic competition is crucial to ensuring that brand-name drugs become more affordable, but some drug companies have resorted to exploitative tactics that delay generic competition."